A Single Site, Open-label, Randomized, Single-dose, Two-way Cross-over Study in Healthy Japanese Subjects to Evaluate the Bioequivalence, Safety and Tolerability of Levetiracetam Administered as an Oral Tablet or Intravenous Infusion.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Levetiracetam (Primary) ; Levetiracetam (Primary)
- Indications Epilepsy; Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors UCB
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2011 New trial record